Establishing a peritoneal dissemination xenograft mouse model for survival outcome assessment of experimental gastric cancer

Journal of Surgical Research

Volumn 182, Issue 2, 2013, Pages 227-234

  Zhang, Changhua ^a,b,c   Awasthi, Niranjan ^a,b   Schwarz, Margaret A ^d   Schwarz, Roderich E ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c THE FIRST AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^d UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

Gastric cancer; Mouse model; Peritoneal dissemination; Survival

Indexed keywords

1 (1 CYANO 1 METHYLETHYL) 3 METHYL 8 (3 QUINOLINYL)IMIDAZO[4,5 C]QUINOLIN 2(1H,3H) ONE; OXALIPLATIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CANCER CELL; CANCER GROWTH; CANCER SIZE; CANCER SURVIVAL; CARCINOGENESIS; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; METASTASIS; MICROVILLUS; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; PERITONEUM CANCER; PERITONEUM TUMOR; PRIORITY JOURNAL; STOMACH CANCER; XENOGRAFT;

ANIMALS; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; IMIDAZOLES; MICE; MICE, SCID; ORGANOPLATINUM COMPOUNDS; PERITONEAL NEOPLASMS; QUINOLINES; STOMACH NEOPLASMS;

EID: 84877718320     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2012.10.052     Document Type: Article

References (28)

1. M. Sasako, M. Inoue, and J.T. Lin Gastric Cancer Working Group report Jpn J Clin Oncol 40 Suppl 1 2010 i28
2. R.E. Schwarz, and D.D. Smith Clinical impact of lymphadenectomy extent in resectable gastric cancer of advanced stage Ann Surg Oncol 14 2007 317
3. C.H. Zhang, W.H. Zhan, and Y.L. He Spleen preservation in radical surgery for gastric cardia cancer Ann Surg Oncol 14 2007 1312
4. Y.J. Bang, Y.W. Kim, and H.K. Yang Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial Lancet 379 2012 315
5. C.H. Yoo, S.H. Noh, and D.W. Shin Recurrence following curative resection for gastric carcinoma Br J Surg 87 2000 236
6. S. Tsujitani, S. Oka, and K. Suzuki Prognostic factors in patients with advanced gastric cancer treated by noncurative resection: a multivariate analysis Hepatogastroenterology 48 2001 1504
7. R.E. Schwarz, and K. Zagala-Nevarez Recurrence patterns after radical gastrectomy for gastric cancer: prognostic factors and implications for postoperative adjuvant therapy Ann Surg Oncol 9 2002 394
8. Y. Maehara, S. Hasuda, and T. Koga Postoperative outcome and sites of recurrence in patients following curative resection of gastric cancer Br J Surg 87 2000 353
9. M. D'Angelica, M. Gonen, and M.F. Brennan Patterns of initial recurrence in completely resected gastric adenocarcinoma Ann Surg 240 2004 808
10. B. Sadeghi, C. Arvieux, and O. Glehen Peritoneal carcinomatosis from nongynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study Cancer 88 2000 358
11. R.S. Kerbel Human tumor xenografts as predictive preclinical models for anticancer drug activity in humans: better than commonly perceived-but they can be improved Cancer Biol Ther 2 4 Suppl 1 2003 S134
12. X. Wang, S.K. Yan, and W.X. Dai A metabonomic approach to chemosensitivity prediction of cisplatin plus 5-fluorouracil in a human xenograft model of gastric cancer Int J Cancer 127 2010 2841
13. L.S. Schwartzberg, F.P. Arena, and D.M. Mintzer Phase II multicenter trial of albumin-bound paclitaxel and capecitabine in first-line treatment of patients with metastatic breast cancer Clin Breast Cancer 12 2012 87
14. E.S. Haley, G.G. Au, and B.R. Carlton Regional administration of oncolytic Echovirus 1 as a novel therapy for the peritoneal dissemination of gastric cancer J Mol Med (Berl) 87 2009 385
15. Y. Yonemura, Y. Endou, and E. Bando Effect of intraperitoneal administration of docetaxel on peritoneal dissemination of gastric cancer Cancer Lett 210 2004 189
16. M.S. Wosnitzer, J. Domingo-Domenech, and M. Castillo-Martin Predictive value of microtubule associated proteins tau and stathmin in patients with nonmuscle invasive bladder cancer receiving adjuvant intravesical taxane therapy J Urol 186 2011 2094
17. S.C. Barranco, C.M. Townsend Jr., and C. Casartelli Establishment and characterization of an in vitro model system for human adenocarcinoma of the stomach Cancer Res 43 1983 1703
18. J.G. Park, H. Frucht, and R.V. LaRocca Characteristics of cell lines established from human gastric carcinoma Cancer Res 50 1990 2773
19. N. Awasthi, C. Zhang, and W. Ruan Evaluation of poly-mechanistic antiangiogenic combinations to enhance cytotoxic therapy response in pancreatic cancer PLoS One 7 2012 e38477
20. Y. Yonemura, Y. Endou, and M. Shinbo Safety and efficacy of bidirectional chemotherapy for treatment of patients with peritoneal dissemination from gastric cancer: selection for cytoreductive surgery J Surg Oncol 100 2009 311
21. J.L. Ku, K.H. Kim, and J.S. Choi Establishment and characterization of six human gastric carcinoma cell lines, including one naturally infected with Epstein-Barr virus Cell Oncol (Dordr) 35 2012 127
22. N. Awasthi, M.A. Schwarz, and R.E. Schwarz Proteasome inhibition enhances antitumour effects of gemcitabine in experimental pancreatic cancer HPB (Oxford) 11 2009 600
23. Y. Yamashita, N. Egashira, and K. Masuguchi Comparison of peripheral neuropathy induced by standard and nanoparticle albumin-bound paclitaxel in rats J Pharmacol Sci 117 2011 116
24. E.A. Murphy, B.K. Majeti, and R. Mukthavaram Targeted nanogels: a versatile platform for drug delivery to tumors Mol Cancer Ther 10 2011 972
25. N. Awasthi, M.A. Schwarz, and R.E. Schwarz Combination effects of bortezomib with gemcitabine and EMAP II in experimental pancreatic cancer Cancer Biol Ther 10 2010 99
26. R. Leite de Oliveira, A. Hamm, and M. Mazzone Growing tumor vessels: more than one way to skin a cat - implications for angiogenesis targeted cancer therapies Mol Aspects Med 32 2011 71
27. F. De Vita, F. Giuliani, and N. Silvestris Current status of targeted therapies in advanced gastric cancer Expert Opin Ther Targets 16 Suppl 2 2012 S29
28. J.J. Tentler, A.C. Tan, and C.D. Weekes Patient-derived tumour xenografts as models for oncology drug development Nat Rev Clin Oncol 9 2012 338